Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > We are # 1

<< Previous

Bullboard Posts

Next >>

Comment by consultant99on Oct 28, 2021 11:27am

484 Views

Post# 34059009

RE:RE:We are # 1

It is sad that shareholders have to beg for scraps of information from a company that has stopped communicating since the disasterous funding of the Phase 2 trial.

There is no share price volatility.
There are few and far between press releases.
The Phase 2 trial is moving along at a snails pace and apparently there is no progress worth sharing on the development front for the other cancer treatments or vaccines.

Watching paint dry is more rewarding than following TLT these days.

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?